BetMGM Betting suggests a favorable betting opportunity on Michael Wacha's Hits Allowed UNDER prop, noting he has hit this under in 7 of his last 10 away games for a solid +3.40 units profit and a 27% ROI. Given the Yankees' selective hitting approach—lowest swing rate against left-handed pitchers—Wacha's consistent performances of limiting hits away from home presents a lucrative betting angle even against a tough New York lineup.

BetMGM Betting underscores Michael Wacha's inability to pitch deep into road games, reporting that his pitching outs UNDER prop has hit in 3 of his last 4 away games for a strong +2.55 units and 61% ROI. Considering Yankees hitters have demonstrated significant patience at the plate (MLB-high 17% walk rate against inning leadoff batters this month), Wacha may struggle to keep pitch counts down, adding value to the under on his pitching outs against this disciplined New York offense.

BetMGM Betting pointed to Michael Wacha's recent concerning trend in road starts, highlighting that he has hit the earned runs OVER prop in 3 of his last 4 away games, generating a +2.20 Units profit and a 53% ROI. His breaking pitches have not found the strike zone consistently, achieving only a 47% strike rate—lowest amongst pitchers with over 70 innings pitched. Facing a Yankees roster at home that slugs .584 and draws walks at an MLB-high rate versus lefties, Wacha's long-term weaknesses away from home are significantly heightened against this dangerous offensive lineup disguised in a hitter-friendly stadium.

Mike Spector likes Michael Wacha to surrender fewer than 2.5 earned runs against the Yankees, despite a shaky start to the season (0-2, 4.20 ERA). Wacha recently showed promise, allowing only two earned runs in 5.1 innings against the Twins. While control issues linger, with three or more walks in two of his first three starts, the matchup against the Yankees is particularly favorable due to Wacha's dominance over Aaron Judge, who is just 1-for-18 lifetime with 11 strikeouts against him. Spector anticipates Wacha will pitch approximately five innings, benefiting from the Yankees' below-average walk rate to better manage his control and minimize damage.

Scott Reichel prefers Kansas City and starter Michael Wacha (-115 money line) over the Orioles, emphasizing Wacha's steadier history and solid performance against the Guardians in his first outing (four innings, one run). Noting Orioles starter Sagano lacks MLB experience with just one start under his belt (four innings, two runs), Reichel is betting on Wacha's consistency and superior sample size. Given both starters won't pitch deep, the game likely depends heavily on bullpen production, but he still prefers trusting Wacha early and advises a potential first-five innings play to eliminate bullpen uncertainty.

Backing Michael Wacha and the Royals in the first five innings is Dylan Rockford's preferred wager against Baltimore. Wacha impressed Dylan in his season debut despite a tough-luck loss, and he likes the idea of relying on the more consistent pitcher with proven success for Kansas City rather than risking uncertainty from both bullpens. Rockford priced Kansas City slightly higher (at -125), providing additional value at the current odds, and sees this as an edge play, specifically through the first half of the game.

Eric Polzin identified Michael Wacha's over pitching fantasy score as another noteworthy MLB prop, judged positively against offered fantasy line data. His confidence is grounded in projections and sportsbook comparisons indicating a clear value edge, despite noting it as slightly better on Underdog than PrizePicks.

JD Bets advised caution fading Michael Wacha who had his first start delayed due to food poisoning from Chipotle, noting that players often feel weak and subpar after such illnesses. Despite Wacha's respectable previous season of 13-8 with a 3.35 ERA, JD emphasizes that immediate recovery from food poisoning can cause athletes to underperform, suggesting bettors slightly fade Wacha in this first official start due to lingering health effects.